Literature DB >> 19340016

Validation of oligonucleotide-mediated gene editing.

P Disterer1, J P Simons, J S Owen.   

Abstract

Several independent groups have reported targeted genomic editing in mammalian cells mediated by synthetic oligonucleotides. Nevertheless, the validity of data has been disputed because of experimental artefacts, inconsistent findings and low reproducibility. Here, we describe experiments designed to meet stringent criteria and completely eliminate artefactual results. In particular, by targeting cells expressing mutated enhanced green fluorescence protein (EGFP), which allow editing measurements at the protein level, and analyzing corrected clones by Southern blotting, we rigorously excluded spontaneous reversion, contamination artefacts, false-positives, or overestimation. Our findings provide unequivocal authentication that oligonucleotide-mediated gene editing is a real, not artefactual, phenomenon--a vital starting point from which to develop the technology into practical applications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19340016     DOI: 10.1038/gt.2009.32

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  3 in total

1.  Targeted In Situ Gene Correction of Dysfunctional APOE Alleles to Produce Atheroprotective Plasma ApoE3 Protein.

Authors:  Ioannis Papaioannou; J Paul Simons; James S Owen
Journal:  Cardiol Res Pract       Date:  2012-05-07       Impact factor: 1.866

2.  Stable gene targeting in human cells using single-strand oligonucleotides with modified bases.

Authors:  Xavier Rios; Adrian W Briggs; Danos Christodoulou; Josh M Gorham; Jonathan G Seidman; George M Church
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

Review 3.  Emerging gene editing strategies for Duchenne muscular dystrophy targeting stem cells.

Authors:  Carmen Bertoni
Journal:  Front Physiol       Date:  2014-04-21       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.